Identification of HRPAP20: A Novel Phosphoprotein that Enhances Growth and Survival in Hormone-Responsive Tumor Cells

Cancer Research

Volumn 64, Issue 3, 2004, Pages 1016-1025

  Karp, Cristina M ^a   Pan, Huiqui ^a   Zhang, Mingyu ^a   Buckley, Donna J ^a   Schuler, Linda A ^b   Buckley, Arthur R ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; COLECALCIFEROL; GENE PRODUCT; HORMONE REGULATED PROLIFERATION ASSOCIATED PROTEIN 20; PHOSPHOPROTEIN; PROLACTIN; PROTEIN; RETINOIC ACID; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL SYNCHRONIZATION; CONTROLLED STUDY; DNA SEQUENCE; GENETIC TRANSFECTION; HORMONAL REGULATION; HORMONE DEPENDENCE; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOMA; LYMPHOMA CELL; MOLECULAR MECHANICS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEQUENCE ANALYSIS; TUMOR GROWTH;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CHICKENS; CLONING, MOLECULAR; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, T-CELL; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS, HORMONE-DEPENDENT; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0842282617     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0023     Document Type: Article

References (45)

1. Gout, P. W., Beer, C. T., and Noble, R. L. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res., 40: 2433-2436, 1980.
2. Gout, P. W. Transient requirement for prolactin as a growth initiator following treatment of autonomous Nb2 node rat lymphoma cell cultures with butyrate. Cancer Res., 47: 1751-1755, 1987.
3. Gout, P. W., Horsman, D. E., Fox, K., De Jong, G., Ma, S., and Bruchovsky, N. The rat Nb2 lymphoma: a novel model for tumor progression. Anticancer Res., 14: 2485-2492, 1994.
4. Kuller, L. H. The etiology of breast cancer-from epidemiology to prevention. Public Health Rev., 23: 157-213, 1995.
5. Ernester, V. L., Barclay, J., Kerlikowske, K., Grady, D., and Henderson, C. Incidence of and treatment for ductal carcinoma in situ of the breast. J. Am. Med. Assoc., 275: 913-918, 1996.
6. Breast Cancer Facts & Figures 2001-2002. American Cancer Society monograph, 2002.
7. Gompel G., and van Kerkem C. The breast. In: S. Silverberg (ed.), Principles of Surgical Pathology, pp. 245-255. New York: Wiley Medical, 1983.
8. Harris J. R., Hellman S., Canellos, G. P., and Fischer, B. Cancer of the breast. In: V. T. deVita, and S. A. Rosenberg (eds.), Cancer Principles and Practice of Oncology, pp. 119-1179. Philadelphia: J. B. Lippincott, 1982.
9. Lynch, H. T., Albano, W. A., Danes, S., Layton, M. A., Kimberling, W. J., and Lynch, J. F. Genetic predisposition to breast cancer. Cancer (Phila.), 53: 612-622, 1984.
10. Vorherr, H. Breast cancer: epidemiology, endocrinology, biochemistry, and pathology. Baltimore: Urban & Scharzenberg, 1980.
11. Arafah, B. M., and Pearson, O. H. Endocrine treatment of advanced breast cancer. In: V. C. Jordan (ed.), Estrogen/Antiestrogen Action and Human Breast Cancer Therapy, pp. 417-429. Madison, WI: University of Wisconsin Press, 1986.
12. Leonessa, F., Boulay, V., Wright, A., Thompson, E. W., Brunner, N., and Clarke, R. The biology of breast tumor progression. Acquisition of hormone independence and resistance to cytotoxic drugs. Acta Oncol., 31: 115-123, 1992.
13. Buckley, A. R., Buckley, D. J., Leff, M. A., Hoover, D. S., and Magnuson, N. S. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology, 136: 5252-5259, 1995.
14. Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L., Montone, K. T., and Tomaszewski, J. E. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol., 146: 695-705, 1995.
15. Clevenger, C. V., Furth, P. A., Hankinson, S. E., and Schuler, L. A. The role of prolactin in mammary carcinoma. Endocr. Rev., 24: 1-27, 2003.
16. Schroeder, M. D., Symowicz, J., and Schuler L. A. PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol. Endocrinol., 16: 45-57, 2002.
17. Feinberg, A. P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6-13, 1983.
18. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
19. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Taraganos, F. Features of apoptotic cells measured by flow cytometry. Cytometry, 13: 795-808, 1992.
20. Macdonald, F., and Ford, C. H. J. Molecular Biology of Cancer. Oxford: Bios Scientific Publishers, 1997.
21. Simstein, R., Burow, M., Parker, A., Weldon, C., and Beckman, B. Apoptosis, chemoresistance, and breast cancer: insights from the mcf-7 model system. Exp. Biol. Med., 228: 995-1003, 2003.
22. Liang, P., and Pardee, A. B. Differential display methods and protocols. Meth. Mol. Biol., 85: 3-5, 1997.
23. Liang, P., and Pardee, A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Wash. DC), 257: 967-971, 1992.
24. Shafie, S. M., and Grantham, F. H. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. Natl. Cancer Inst. (Bethesda), 67: 51-60, 1981.
25. Barnard, J. A., and Warwick, G. Butyrate rapidly induces growth inhibition and differentiation in HT-29 cells. Cell Growth Differ., 4: 495-501, 1993.
26. Bonnotte, B., Favre, N., Reveneau, S., Micheau, O., Droin, N., Garrido, C., Fontana, A., Chauffert, B., Solary, E., and Martin, F. Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate. Cell Death Differ., 5: 480-487, 1998.
27. Kruh, J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol. Cell. Biochem., 42: 65-82, 1982.
28. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Soc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
29. Chomienne, C., Ballerini, P., Baltitrand, N., Huang, M. E., Krawice, I., Castaigne, S., Fenaux, P., Dejean, A., Degos, L., and de The, H. The retinoic acid receptor α gene is rearranged in retinoic acid-sensitive promyelocytic leukemias. Leukemia (Baltimore), 4: 802-807, 1990.
30. Bollag, W., and Holdener, E. E. Retinoids in cancer prevention and therapy. Ann. Oncol., 3: 513-526, 1992.
31. Zhu, W. Y., Jones, C. S., Amin, S., Matsukuma, K., Haque, M., Vuligonda, V., Chandraratna, R. A., and De Luca, L. M. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells. Cancer Res., 59: 85-90, 1999.
32. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J., 10: 941-954, 1996.
33. 3 receptor. Cell, 65: 1255-1266, 1991.
34. 3-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex. J. Exp. Med., 190: 1593-1594, 1999.
35. Horseman, D., Masui, S., and Gout, P. W. Karyotypic changes associated with loss of prolactin dependency of rat Nb2 node lymphoma cell cultures. Cancer Res., 51: 282-287, 1991.
36. Buckley, A. R., Leff, M. A., Buckley, D. J., Magnuson, N. S., de Jong, G., and Gout, P. W. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells. Cell Growth Differ., 7: 1713-1721, 1996.
37. Fenton, S. E., and Sheffield, L. G. Prolactin inhibits EGF-induced DNA synthesis in mammary epithelium via early signaling mechanisms: possible involvement of protein kinase C. Exp. Cell Res., 236: 285-293, 1997.
38. Buckley, A. R., Montgomery, D. W., Kibler, R., Putnam, C. W., Zukoski, C. F., Gout, P. W., Beer, C. T., and Russell, D. H. Prolactin stimulation of ornithine decarboxylase and mitogenesis in Nb2 node lymphoma cells: the role of protein kinase C and calcium mobilization. Immunopharmacology, 12: 37-51, 1986.
39. Waters, S. B., and Rillema, J. A. Role of protein kinase C in the prolactin-induced responses in mouse mammary gland explants. Mol. Cell. Endocrinol., 63: 159-166, 1989.
40. Swat, W., Ignatowicz, L., and Kisielow, P., Detection of apoptosis of immature CD4+8+ thymocytes by flow cytometry. J. Immunol. Methods, 137: 79-87, 1991.
41. Collins, M. K., Perkins, G. R., Rodriguez-Tarduchy, G., Nieto, M. A., and Lopez-Rivas, A. Growth factors as survival factors: regulation of apoptosis. Bioessays., 16: 133-138, 1994.
42. Darzynkiewicz, Z., Juan, G., Li, X., Gorczyca, W., Murakami, T., and Traganos, F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 27: 1-20, 1997.
43. van Engeland, M., Nieland, L. J. W., Ramaekers, F. C. S., Schutte, B., and Reutelingsperger, C. P. M. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry, 31: 1-9, 1998.
44. Del Bino, G., Darzynkiewicz, Z., Degraef, C., Mosselmans, R., Fokan, D., and Galand, P. Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Prolif., 32: 25-37, 1999.
45. Jänicke, R. U., Sprengart, M. L., Wati, M. R., and Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem., 273: 9357-9360, 1998.